DS
CDLX icon

David Shaw’s Cardlytics CDLX Stock Holding History

David Shaw’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,621
Closed -$30.1K – 4588
2025
Q4 		$30.1K Sell
2,621
-6,487
-71% -$100K ﹤0.01% 4462
2025
Q3 		$221K Sell
9,108
-41,387
-82% -$689K ﹤0.01% 4242
2025
Q2 		$831K Sell
50,495
-35,666
-41% -$616K ﹤0.01% 3357
2025
Q1 		$1.57M Sell
86,161
-26,990
-24% -$771K ﹤0.01% 2789
2024
Q4 		$4.2M Buy
113,151
+55,824
+97% +$2.14M ﹤0.01% 2114
2024
Q3 		$1.83M Buy
57,327
+48,436
+545% +$2.69M ﹤0.01% 2770
2024
Q2 		$730K Sell
8,891
-41,542
-82% -$4.49M ﹤0.01% 3385
2024
Q1 		$7.31M Sell
50,433
-14,248
-22% -$1.2M 0.01% 1610
2023
Q4 		$5.96M Sell
64,681
-5,613
-8% -$571K 0.01% 1769
2023
Q3 		$11.6M Sell
70,294
-33,369
-32% -$4.34M 0.01% 1189
2023
Q2 		$6.55M Sell
103,663
-8,760
-8% -$531K 0.01% 1662
2023
Q1 		$3.82M Sell
112,423
-15,125
-12% -$790K ﹤0.01% 2179
2022
Q4 		$7.37M Buy
127,548
+106,067
+494% +$6.55M 0.01% 1723
2022
Q3 		$2.02M Buy
21,481
+10,893
+103% +$1.55M ﹤0.01% 2999
2022
Q2 		$2.36M Buy
10,588
+9,622
+996% +$3.22M ﹤0.01% 2927
2022
Q1 		$531K Sell
966
-1,280
-57% -$774K ﹤0.01% 4332
2021
Q4 		$1.48M Buy
2,246
+1,770
+372% +$1.35M ﹤0.01% 3615
2021
Q3 		$399K Sell
476
-30
-6% -$30.4K ﹤0.01% 4211
2021
Q2 		$642K Sell
506
-4,301
-89% -$4.85M ﹤0.01% 3888
2021
Q1 		$5.27M Buy
4,807
+1,287
+37% +$1.7M 0.01% 1803
2020
Q4 		$5.03M Sell
3,520
-4,642
-57% -$4.95M ﹤0.01% 1863
2020
Q3 		$5.76M Buy
8,162
+2,965
+57% +$2.16M 0.01% 1593
2020
Q2 		$3.64M Sell
5,197
-5,320
-51% -$3.07M ﹤0.01% 1914
2020
Q1 		$3.68M Sell
10,517
-30,186
-74% -$21.4M 0.01% 1698
2019
Q4 		$25.6M Buy
+40,703
New +$19.9M 0.03% 686

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

David Shaw's CDLX Position: Q1 2026 in Review

David Shaw sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 2,621 shares — an estimated $30.1K sold.

David Shaw first reported a position in CDLX in Q4 2019 and held it in 25 quarters. The position peaked at $25.6M in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • David Shaw reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 2,621 Cardlytics shares in Q1 2026, an estimated $30.1K.
  • David Shaw first reported a position in Cardlytics in Q4 2019 and held it in 25 quarters.
  • David Shaw's Cardlytics position peaked at $25.6M in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.